Unknown

Dataset Information

0

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.


ABSTRACT: BACKGROUND:Microarray-based gene expression profiling is a powerful approach for the identification of molecular biomarkers of disease, particularly in human cancers. Utility of this approach to measure responses to therapy is less well established, in part due to challenges in obtaining serial biopsies. Identification of suitable surrogate tissues will help minimize limitations imposed by those challenges. This study describes an approach used to identify gene expression changes that might serve as surrogate biomarkers of drug activity. METHODS:Expression profiling using microarrays was applied to peripheral blood mononuclear cell (PBMC) samples obtained from patients with advanced colorectal cancer participating in a Phase III clinical trial. The PBMC samples were harvested pre-treatment and at the end of the first 6-week cycle from patients receiving standard of care chemotherapy or standard of care plus SU5416, a vascular endothelial growth factor (VEGF) receptor tyrosine kinase (RTK) inhibitor. Results from matched pairs of PBMC samples from 23 patients were queried for expression changes that consistently correlated with SU5416 administration. RESULTS:Thirteen transcripts met this selection criterion; six were further tested by quantitative RT-PCR analysis of 62 additional samples from this trial and a second SU5416 Phase III trial of similar design. This method confirmed four of these transcripts (CD24, lactoferrin, lipocalin 2, and MMP-9) as potential biomarkers of drug treatment. Discriminant analysis showed that expression profiles of these 4 transcripts could be used to classify patients by treatment arm in a predictive fashion. CONCLUSIONS:These results establish a foundation for the further exploration of peripheral blood cells as a surrogate system for biomarker analyses in clinical oncology studies.

SUBMITTER: DePrimo SE 

PROVIDER: S-EPMC152639 | biostudies-literature | 2003 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.

DePrimo Samuel E SE   Wong Lily M LM   Khatry Deepak B DB   Nicholas Susan L SL   Manning William C WC   Smolich Beverly D BD   O'Farrell Anne-Marie AM   Cherrington Julie M JM  

BMC cancer 20030207


<h4>Background</h4>Microarray-based gene expression profiling is a powerful approach for the identification of molecular biomarkers of disease, particularly in human cancers. Utility of this approach to measure responses to therapy is less well established, in part due to challenges in obtaining serial biopsies. Identification of suitable surrogate tissues will help minimize limitations imposed by those challenges. This study describes an approach used to identify gene expression changes that mi  ...[more]

Similar Datasets

| S-EPMC5466800 | biostudies-literature
| S-EPMC3296081 | biostudies-other
| S-EPMC4847814 | biostudies-literature
| S-EPMC8488800 | biostudies-literature
| S-EPMC6336001 | biostudies-literature
| S-EPMC9264965 | biostudies-literature
| S-EPMC6175670 | biostudies-literature
| S-EPMC2813741 | biostudies-other
| S-EPMC7324435 | biostudies-literature
| S-EPMC4434855 | biostudies-literature